BackSequent Scientific Limited Overview
Sequent Scientific Limited

Sequent Scientific Limited Return on Equity

Valuation check: SEQUENT.NS's ROE is 5.5%, below the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

5.50%

Return on Equity

5.50%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Sequent Scientific Limited (SEQUENT.NS) FAQ

The latest ROE for SEQUENT.NS is 5.5%. That is below the sector sector average of 11.3%. Investors often review this figure alongside Sequent Scientific Limited's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, SEQUENT.NS currently prints 5.5% for ROE, while the sector average sits near 11.3%. That is roughly 51.4% below the sector mean. Large gaps often invite a closer look at Sequent Scientific Limited's growth, margins, and balance sheet.

Return on Equity shows how effectively Sequent Scientific Limited converts resources into returns. At 5.5%, SEQUENT.NS may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SEQUENT.NS's ROE (5.5%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.